143 related articles for article (PubMed ID: 8019051)
1. Prescribing CNS drugs for elderly patients.
Ghose K
Drugs Aging; 1994 Apr; 4(4):275-84. PubMed ID: 8019051
[No Abstract] [Full Text] [Related]
2. Inappropriate medication prescribing for elderly ambulatory care patients.
Goulding MR
Arch Intern Med; 2004 Feb; 164(3):305-12. PubMed ID: 14769626
[TBL] [Abstract][Full Text] [Related]
3. [The interaction of drugs acting predominantly on the CNS].
Zelikson IuI; Davydova ON
Med Sestra; 1988 Nov; 47(11):45-52. PubMed ID: 3221755
[No Abstract] [Full Text] [Related]
4. CNS-active drugs in aging population at high risk of cerebrovascular events: evidence from preclinical and clinical studies.
Zhao CS; Hartikainen S; Schallert T; Sivenius J; Jolkkonen J
Neurosci Biobehav Rev; 2008; 32(1):56-71. PubMed ID: 17599405
[TBL] [Abstract][Full Text] [Related]
5. Adverse reactions related to drugs for headache treatment: clinical impact.
Ferrari A; Ottani A; Bertolini A; Cicero AF; Coccia CP; Leone S; Sternieri E
Eur J Clin Pharmacol; 2005 Feb; 60(12):893-900. PubMed ID: 15657778
[TBL] [Abstract][Full Text] [Related]
6. Regioselective biotransformation of CNS drugs and its clinical impact on adverse drug reactions.
Wong YC; Qian S; Zuo Z
Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):833-54. PubMed ID: 22568396
[TBL] [Abstract][Full Text] [Related]
7. Adverse reactions to drugs in general practice.
Martys CR
Br Med J; 1979 Nov; 2(6199):1194-7. PubMed ID: 42471
[TBL] [Abstract][Full Text] [Related]
8. The role of pharmacogenetics in treating central nervous system disorders.
Patnaik M; Renda MJ; Athanasiou MC; Reed CR
Exp Biol Med (Maywood); 2008 Dec; 233(12):1504-9. PubMed ID: 18849543
[TBL] [Abstract][Full Text] [Related]
9. Drug development for CNS disorders: strategies for balancing risk and reducing attrition.
Pangalos MN; Schechter LE; Hurko O
Nat Rev Drug Discov; 2007 Jul; 6(7):521-32. PubMed ID: 17599084
[TBL] [Abstract][Full Text] [Related]
10. Drugs and mood changes.
Kitchen I
Nursing (Lond); 1984 Apr; 2(24):719-21. PubMed ID: 6563458
[No Abstract] [Full Text] [Related]
11. Medication and falls: risk and optimization.
Boyle N; Naganathan V; Cumming RG
Clin Geriatr Med; 2010 Nov; 26(4):583-605. PubMed ID: 20934612
[TBL] [Abstract][Full Text] [Related]
12. Centrally acting drugs.
Bateman DN; Chaplin S
Br Med J (Clin Res Ed); 1988 Feb; 296(6619):417-9. PubMed ID: 3125927
[No Abstract] [Full Text] [Related]
13. FDA-approved drugs to treat sleep disorders.
J Psychosoc Nurs Ment Health Serv; 2012 Oct; 50(10):9-10. PubMed ID: 23053622
[No Abstract] [Full Text] [Related]
14. [New drugs in neurology].
Mattle HP
Praxis (Bern 1994); 1999 Apr; 88(18):827-34. PubMed ID: 10409881
[TBL] [Abstract][Full Text] [Related]
15. The use of central nervous system drugs and analgesics among very old people with and without dementia.
Lövheim H; Karlsson S; Gustafson Y
Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):912-8. PubMed ID: 18398935
[TBL] [Abstract][Full Text] [Related]
16. The rhinological side-effects of systemic drugs.
Bateman ND; Woolford TJ
Clin Otolaryngol Allied Sci; 2003 Oct; 28(5):381-5. PubMed ID: 12969337
[TBL] [Abstract][Full Text] [Related]
17. Positive Beers criteria: limitations.
Linnebur SA; Vande Griend JP; Dugan JP; Page RL
Consult Pharm; 2009 Nov; 24(11):792; author reply 792, 794. PubMed ID: 20092217
[No Abstract] [Full Text] [Related]
18. Journal of Child and Adolescent Psychopharmacology. From the Editor-in-Chief's desk.
Koplewicz HS
J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):431. PubMed ID: 24041407
[No Abstract] [Full Text] [Related]
19. Avoiding adverse drug effects in elderly patients.
Leipzig RM
Cleve Clin J Med; 1998 Oct; 65(9):470-8. PubMed ID: 9795488
[TBL] [Abstract][Full Text] [Related]
20. A guide to the safety of CNS-active agents during breastfeeding.
Chisholm CA; Kuller JA
Drug Saf; 1997 Aug; 17(2):127-42. PubMed ID: 9285203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
